Recent changes

Jump to: navigation, search

Track the most recent changes to the wiki on this page.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 10:05, 24 March 2017
   

23 March 2017

N    18:45  Avelumab (Bavencio) for merkel cell carcinoma‎‎ (2 changes | history) . . (+2,713). . [PeterYang‎ (2×)]
 m    18:45 (cur | prev) . . (-88). . PeterYang (talk | contribs)
N     18:41 (cur | prev) . . (+2,801). . PeterYang (talk | contribs) (Created page with "<includeonly>Source: Avelumab (Bavencio) for merkel cell carcinoma {| class="wikitable" style="float:right; margin-left: 5px;" |- |back to top |}</includeonly> {|...")
     18:44  Merkel cell carcinoma‎‎ (2 changes | history) . . (+91). . [PeterYang‎ (2×)]
      18:44 (cur | prev) . . (-2,336). . PeterYang (talk | contribs) (transclusion)
      17:04 (cur | prev) . . (+2,427). . PeterYang (talk | contribs) (added regimen)
N    18:41  Category:Merkel cell carcinoma regimens‎ (diff | hist) . . (+36). . PeterYang (talk | contribs) (Created page with "Category:Solid oncology regimens")
N    17:42  Tremelimumab (ticilimumab)‎ (diff | hist) . . (+1,698). . PeterYang (talk | contribs) (Created page with "'''in clinical trials''' ==General information== Class/mechanism: Anti-CTLA-4 antibody. CTLA-4 is a negative regulator of T-cell activation and ipilimumab interferes with th...")
 m   17:37  Drug index‎‎ (3 changes | history) . . (+163). . [PeterYang‎ (3×)]
 m    17:37 (cur | prev) . . (+57). . PeterYang (talk | contribs) (T)
 m    17:27 (cur | prev) . . (+52). . PeterYang (talk | contribs) (D)
 m    15:51 (cur | prev) . . (+54). . PeterYang (talk | contribs) (FDA approval)
N    17:34  Durvalumab (MEDI4736)‎ (diff | hist) . . (+2,010). . PeterYang (talk | contribs) (Created page with "'''in clinical trials''' ==General information== Class/mechanism: PD-L1 blocking antibody. PD-L1 (programmed death-1 ligand 1) expressed on tumor cells and tumor-infiltrating...")
 m   16:55  Acetaminophen (Tylenol)‎ (diff | hist) . . (+32). . PeterYang (talk | contribs)
N    16:14  Avelumab (Bavencio)‎ (diff | hist) . . (+2,180). . PeterYang (talk | contribs) (FDA approval)
     15:53  (Upload log). . [PeterYang‎ (10×)]
      15:53 . . PeterYang (talk | contribs) uploaded File:Avelumab.pdf(Avelumab (Bavencio) package insert (locally hosted backup). Original source: http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761049s000lbl.pdf, accessed 3/23/2017.)
      03:30 . . PeterYang (talk | contribs) uploaded a new version of File:Factorviiixyntha.pdf(Factor VIII, recombinant (Xyntha) package insert (locally hosted backup). Original source: http://labeling.pfizer.com/showlabeling.aspx?id=496, accessed 3/23/2017.)
      03:26 . . PeterYang (talk | contribs) uploaded a new version of File:Factorviiimonoclate.pdf(Factor VIII, human (Monoclate-P) package insert (locally hosted backup). Original source: http://labeling.cslbehring.com/PI/US/Monoclate-P/EN/Monoclate-P-Prescribing-Information.pdf, accessed 3/23/2017.)
      03:21 . . PeterYang (talk | contribs) uploaded a new version of File:Factorviiikogenate.pdf(Factor VIII, recombinant (Kogenate FS) package insert (locally hosted backup). Original source: http://labeling.bayerhealthcare.com/html/products/pi/Kogenate_BIO-SET_PI.pdf, accessed 3/23/2017.)
      02:42 . . PeterYang (talk | contribs) uploaded a new version of File:Factorviiikoate.pdf(Factor VIII, human (Koate-DVI) package insert (locally hosted backup). Original source: http://www.koate-dvi.com/documents/809754/0/Koate_DVI.pdf/fb455459-5ac0-43d3-bb48-363389a7c5c3, accessed 3/23/2017.)
      02:36 . . PeterYang (talk | contribs) uploaded a new version of File:Factorviiihemofil.pdf(Factor VIII, human (Hemofil-M) package insert (locally hosted backup). Original source: http://www.shirecontent.com/PI/PDFs/HEMOFILM_USA_ENG.pdf, accessed 3/23/2017.)
      02:34 . . PeterYang (talk | contribs) uploaded a new version of File:Factorviiihelixate.pdf(Factor VIII, recombinant (Helixate FS) package insert (locally hosted backup). Original source: http://labeling.cslbehring.com/PI/US/HelixateFS/EN/HelixateFS-Prescribing-Information.pdf, accessed 3/23/2017.)
      02:33 . . PeterYang (talk | contribs) uploaded a new version of File:Factorviiiadvate.pdf(Factor VIII, recombinant (Advate) package insert (locally hosted backup). Original source: http://advate.com/pdf/advate_iri_pi.pdf, accessed 3/23/2017.)
      02:28 . . PeterYang (talk | contribs) uploaded a new version of File:Leuprolideeligard.pdf(Leuprolide (Eligard) package insert (locally hosted backup). Original source: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b78d1919-9dee-44fa-90f9-e0a26d32481d, accessed 3/23/2017.)
      02:26 . . PeterYang (talk | contribs) uploaded a new version of File:Leuprolidelupron.pdf(Leuprolide (Lupron) package insert (locally hosted backup). Original source: http://www.rxabbvie.com/pdf/lupronuro_pi.pdf, accessed 3/23/2017.)
     03:31  Factor VIII, human and recombinant (antihemophilic factor 8)‎ (diff | hist) . . (-160). . PeterYang (talk | contribs) (updated package inserts)
     02:30  Leuprolide (Lupron)‎ (diff | hist) . . (+120). . PeterYang (talk | contribs) (updated some dead links)
     02:24  Bicalutamide (Casodex)‎ (diff | hist) . . (-111). . PeterYang (talk | contribs)

20 March 2017

     10:38 (User creation log) . . User account Zahera (talk | contribs) was created ‎

19 March 2017

 m   22:27  Erlotinib (Tarceva)‎ (diff | hist) . . (+24). . Jwarner (talk | contribs) (Also known as)
     20:06  User:PeterYang‎ (diff | hist) . . (+132). . PeterYang (talk | contribs) (Personal useful links)
     19:54  Marginal zone lymphoma‎ (diff | hist) . . (+1,324). . PeterYang (talk | contribs) (ibrutinib FDA approval)
     19:44  Ibrutinib (Imbruvica)‎ (diff | hist) . . (+267). . PeterYang (talk | contribs)
     19:38 (Upload log) . . PeterYang (talk | contribs) uploaded a new version of File:Ibrutinib.pdf(Ibrutinib (Imbruvica) package insert (locally hosted backup). Original source: https://www.imbruvica.com/docs/librariesprovider7/default-document-library/prescribing_information.pdf, accessed 3/19/2017.)

18 March 2017

     21:44  Histrelin (Vantas)‎‎ (2 changes | history) . . (+999). . [PeterYang‎ (2×)]
      21:44 (cur | prev) . . (-186). . PeterYang (talk | contribs)
      21:43 (cur | prev) . . (+1,185). . PeterYang (talk | contribs)
 m   21:41  Ado-trastuzumab emtansine (Kadcyla)‎ (diff | hist) . . (+25). . PeterYang (talk | contribs)
     21:39  (Upload log). . [PeterYang‎ (3×)]
      21:39 . . PeterYang (talk | contribs) uploaded File:Histrelin.pdf(Histrelin (Vantas) package insert (locally hosted backup). Original source: http://www.endo.com/File%20Library/Products/Prescribing%20Information/VANTAS.pdf, accessed on 3/18/2017.)
      18:25 . . PeterYang (talk | contribs) uploaded File:Fluorouracil.pdf(Fluorouracil (5-FU) package insert (locally hosted backup). Original source: http://patient.cancerconsultants.com/druginserts/Fluorouracil.pdf.)
      17:49 . . PeterYang (talk | contribs) uploaded File:Mitomycin.pdf(Mitomycin (Mutamycin) package insert (locally hosted backup). Original source: http://docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Ben%20Venue_Bedford%20Labs/55390-251-01%20MIT%205MG/5539025101, accessed 3/18/2017.)
     18:26  Fluorouracil (5-FU)‎ (diff | hist) . . (-141). . PeterYang (talk | contribs)
     17:59  Mitomycin (Mutamycin)‎ (diff | hist) . . (+40). . PeterYang (talk | contribs)

17 March 2017

 m   15:32  Diffuse large B-cell lymphoma‎‎ (2 changes | history) . . (-650). . [Jwarner‎ (2×)]
 m    15:32 (cur | prev) . . (+660). . Jwarner (talk | contribs) (Prognosis)
 m    15:31 (cur | prev) . . (-1,310). . Jwarner (talk | contribs) (Response criteria)
 m   15:29  Mantle cell lymphoma‎ (diff | hist) . . (-342). . Jwarner (talk | contribs) (Response criteria)
     00:42  Samarium-153 (Quadramet)‎ (diff | hist) . . (+440). . PeterYang (talk | contribs)
     00:38  (Upload log). . [PeterYang‎ (4×)]
      00:38 . . PeterYang (talk | contribs) uploaded a new version of File:Samarium153a.pdf(Samarium-153 (Quadramet) package insert (locally hosted backup). Original source: http://www.lantheus.com/assets/quadramet-us-outsert-513145-0114-format-2-3-4-2014.pdf, accessed 3/17/2017.)
      00:34 . . PeterYang (talk | contribs) uploaded File:Samarium153b.pdf(Samarium-153 (Quadramet) package insert (locally hosted backup). Original source: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000150/WC500041751.pdf, accessed 3/17/2017.)
      00:33 . . PeterYang (talk | contribs) uploaded File:Samarium153a.pdf(Samarium-153 (Quadramet) package insert (locally hosted backup). Original source: http://quadramet.jazzpharma.com/QuadrametPI.pdf.)
      00:27 . . PeterYang (talk | contribs) uploaded a new version of File:Radium223.pdf(Radium Ra 223 (Xofigo)‎ package insert (locally hosted backup). Original source: http://labeling.bayerhealthcare.com/html/products/pi/Xofigo_PI.pdf, accessed 3/17/2017.)
 m   00:26  Radium-223 (Xofigo)‎ (diff | hist) . . (+272). . PeterYang (talk | contribs)

16 March 2017

N    21:42  MDS‎ (diff | hist) . . (+38). . PeterYang (talk | contribs) (Redirected page to Myelodysplastic syndrome)
 m   21:41  Nivolumab (Opdivo)‎ (diff | hist) . . (+10). . Jwarner (talk | contribs) (Also known as)